Prazosin in Clinical Practice for Hypertension and PTSD-Related Nightmares

Off-Label Uses with Strong Evidence

• Prazosin is an alpha-1 adrenergic receptor antagonist that reduces CNS sympathetic outflow throughout the brain, making it effective for treating PTSD-associated nightmares 1, 2
• Multiple randomized controlled trials demonstrate prazosin's efficacy in reducing nightmare frequency and intensity in both military veterans and civilians with PTSD 1, 3
• The American Academy of Sleep Medicine supports its use for PTSD-related nightmares, though a recent contradictory study has led to a downgrading of the recommendation strength 3

Dosing for PTSD Nightmares

• For civilians with PTSD-related nightmares, the average effective dose is approximately 3-4 mg/day 4
• Military veterans typically require higher doses, ranging from 9.5-15.6 mg/day 4
• Treatment should start with 1 mg at bedtime to minimize first-dose hypotension risk, then gradually increase by 1-2 mg every few days until clinical response is achieved 4

Side Effects and Precautions

• If discontinued, PTSD-related nightmares may return to baseline intensity 1

Special Considerations

• Patients taking selective serotonin reuptake inhibitors (SSRIs) may have a diminished response to prazosin for PTSD symptoms 4
• Blood pressure should be monitored after the initial dose and with each significant dose increase 4

Monitoring Parameters

• Blood pressure monitoring is essential, particularly after initial dosing and dose increases 4
• Assessment of nightmare frequency and intensity using standardized measures when possible 4